Research Article

Complementary and Alternative Medicine: Evaluation of the impact of Biofield Energy Treatment on L-Cysteine

Dahryn Trivedi¹, Mahendra Kumar Trivedi¹, Alice Branton¹, Gopal Nayak¹ and Snehasis Jana²*

¹Trivedi Global, Inc., Henderson, USA

²Trivedi Science Research Laboratory, India

Submission: February 12, 2019; Published: March 08, 2019

*Corresponding author: Snehasis Jana, Trivedi Science Research Laboratory, India

How to cite this article: Dahryn T, Mahendra K T, Alice B, Gopal N, Snehasis J. Complementary and Alternative Medicine: Evaluation of the impact of Biofield Energy Treatment on L-Cysteine. J Phy Fit Treatment & Sports. 2019; 6(1): 555680. DOI:10.19080/JPFMTS.2018.05.555680

Abstract

L-cysteine is a semi-essential amino acid that is also used in alternative medicine to treat cardiovascular disease, inflammation, angina, chronic bronchitis, chronic obstructive pulmonary disease, diabetes, osteoarthritis, flu, etc. This study was aimed to analyze the changes in the L-cysteine regarding its physicochemical and thermal properties due to the impact of the Trivedi Effect® - Consciousness Energy Healing Treatment. The L-cysteine was divided into the control and treated parts among which, the control sample was not given any treatment; while the treated sample received the Trivedi Effect®-Biofield Energy Healing Treatment, remotely, by a well-known Biofield Energy Healer, Dahryn Trivedi. The results indicated a significant impact of the Biofield Energy Treatment on the particle size distribution of the treated sample as the particle sizes were significantly decreased by 10.18% (d₁₀), 12.97% (d₅₀), 16.83% (d₉₀), and 14.36% [D (4, 3)] compared with the control sample. Hence, the resultant surface area of the treated sample was increased by 14.29% compared with the control sample. The PXRD diffractograms of the treated sample showed alterations in the intensities and crystallite sizes ranging from -47.62% to 110.11% and -17.74% to -74.57%, respectively, along with 49.81% decrease in the average crystallite size, compared with the control L-cysteine sample. The latent heat of decompositions of the treated sample was significantly increased by 11.45% and 20.79%, respectively, compared with the control L-cysteine sample. The total weight loss was significantly reduced in the treated L-cysteine sample by 5.59%; however, the residue weight was remarkably increased by 1111.20%, compared with the control sample. Thus, the overall study indicated the importance of the Biofield Energy treatment in the alteration of the particle size, surface area, crystalline properties, and thermal properties of the L-cysteine sample compared with the control sample. Therefore, it could be considered that Biofield Energy Treated L-cysteine might show better solubility, bioavailability, and thermal stability compared with the control sample..

Keywords: L-cysteine, The Trivedi Effect®; Energy of Consciousness Healing Treatment; PSA; PXRD; DSC; TGA

Introduction

L-Cysteine is a semi-essential amino acid for the human body where it is available in the extracellular space in the form of L-cystine, mainly. It is classified as semi-essential as it could be biosynthesized by the body in some amount in the presence of normal conditions. The process of biosynthesis requires methionine, through which it gets the sulfur that is necessary for this process of making the amino acid. Therefore, it also makes the sulphur under the classification of an essential nutrient for the human body [1]. A transport system helps the transfer of extracellular L-cystine within the cells across the plasma membrane where it gets reduced in the form of L-cysteine by the help of thioredoxin and reduced glutathione. The role of intracellular L-cysteine is quite evident in the process of cellular homeostasis. It also acts as a precursor for the synthesis of protein as well as the production of GSH, hydrogen sulfide, and taurine [2,3]. The use of L-cysteine is also evident in the alternative medicine as a natural treatment for cardiovascular disease, inflammation, angina, chronic bronchitis, diabetes, osteoarthritis, flu, and inflammatory bowel disease, etc. [4-7]. It is also used in improving the health of lungs in chronic obstructive pulmonary disease (COPD) patients, which is considered as the third most common cause of death in the United States [8].

The natural food resources that contain L-cysteine are dairy products, meat, eggs, legumes, oats, and vegetables such as, broccoli, garlic, Brussels sprouts, granola, onions, sprouted lentils, and peppers. Some studies also reported the use of L-cysteine in the prevention of colon cancer, promoting the detox, and boosting sports performance. The main health benefits of L-cysteine are supposed to occur from its antioxidant properties that also support the ability of the body in managing the blood sugar, digestive health, and the skin’s appearance [9-11]. L-cysteine is also used widely for breaking up the mucus caused by the pulmonary and respiratory conditions and it also helps in regulating the level of glutamate within the body that ultimately affects the neurons taking part in the central nervous system [12,13]. The L-cysteine deficiency might occur in the elderly and infant’s population that are unable to biosynthesize it within the body. Besides, the people having metabolic syndrome and some malabsorption issues may also have the deficiency of L-cysteine. Its deficiency can cause a slow recovery from injury and other diseases due to the compromised immune system resulted from insufficient L-cysteine in the body [14,15]. Thus, it is provided by the healthcare professionals in the form of pharmaceutical/nutraceutical formulations to supplement the bodily need. The amino acids, such as L-cysteine, are highly affected by their physicochemical properties in terms of their biological performance. Therefore, various researchers were working in this field to enhance the performance of amino acids in the body by altering the physicochemical and thermal profile, such as the particle size, surface area, crystalline structure, and melting point, etc. [16,17].

In recent days, the Biofield Energy Treatment is also used by various researchers to enhance the performance of various compounds due to its significant impact on the living and non-living objects [18,19]. The Biofield Energy is a type of energy medicine that is used as the Complementary and Alternative Medicine (CAM) and includes the traditional as well as the contemporary models and approach to fight against various diseases [20-22]. The living organisms are known to have unique energy surrounding their body, which is known as the Biofield Energy that is an infinite and para-dimensional electromagnetic field. The Trivedi Effect® is a natural and methodically proven phenomenon in which an individual can harness this inherently intelligent energy and transfer it anywhere on the planet via the possible mediation of neutrinos [23]. The Consciousness Energy Healing Treatment has been reported for its remarkable effects in the field of biotechnology [24,25], agriculture science [26,27], human health and wellness [28-30], microbiology [31-33], livestock [34], and metals and ceramics [35,36]. The significant impact of the Trivedi Effect® is also established scientifically on the physicochemical and thermal properties of various pharmaceutical/nutraceutical and organic compounds [37-39]. Thus, this study was executed to determine the effect of the Consciousness Energy Healing Treatment on the physicochemical and thermal properties of L-cysteine by using the analytical techniques such as particle size analysis (PSA), powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA)/differential thermogravimetric analysis (DTG).

Materials and Methods

Chemicals and Reagents

L-cysteine was purchased from Alfa Aesar, USA. Other chemicals which used during the experiments were of analytical grade purchased in India.

Consciousness Energy Healing Treatment Strategies

In this study, the L-cysteine was used as the test compound that was divided into the control and Biofield Energy Treated parts. The control sample was not given any treatment; whereas, the treated part remotely received the Consciousness Energy Healing Treatment by the well-known Biofield Energy Healer, Dahryn Trivedi (USA). The treatment process involves keeping the sample under the standard laboratory conditions followed by providing the Trivedi Effect® - Consciousness Energy Healing Treatment by the Biofield Energy Healer for 3 minutes through the Unique Energy Transmission process. Besides, the control sample was subjected to a “sham” healer under similar laboratory conditions, who did not have any knowledge about the Biofield Energy Treatment. After the treatment, the control and the Biofield Energy Treated samples were kept in similar sealed conditions and further characterized by using modern analytical techniques.

Characterization

The physicochemical and thermal analysis of L-cysteine was performed. The PSA was performed using Malvern Mastersizer 2000, from the UK using the wet method [40,41]. The PXRD analysis of the L-cysteine powder sample was performed with the help of Rigaku MiniFlex-II Desktop X-ray diffractometer (Japan) [42,43]. The average size of crystallites was calculated from PXRD data using the Scherrer’s formula (1):

Where G is the crystallite size in nm, k is the equipment constant, λ is the radiation wavelength, β is the full-width at half maximum, and θ is the Bragg angle [44].

Similarly, the DSC analysis of L-cysteine was performed with the help of DSC Q200, TA instruments. The TGA/DTG thermograms of L-cysteine were obtained with the help of TGA Q50 TA instruments [40,41]. The % change in specific surface area, particle size, crystallite size, peak intensity, melting point, latent heat, weight loss and the maximum thermal degradation temperature of the Biofield Energy Treated L-cysteine was calculated compared with the control sample using the following equation 2:

Results and Discussion

Particle Size Analysis (PSA)

The particle size analysis helps in determining the impact of the Biofield Energy treatment on the particle size distribution of the treated L-cysteine samples in comparison to the control sample. The results revealed that the particle size distribution corresponding to d₁₀, d₅₀, d₉₀, and D (4, 3) of the Biofield Energy Treated L-cysteine sample was significantly decreased by 10.18%, 12.97%, 16.83%, and 14.36%, respectively in comparison to the control sample (Table 1).

d₁₀, d₅₀, d₉₀: particle diameter corresponding to 10%, 50%, and 90% of the cumulative distribution, D (4,3): the average mass-volume diameter, and SSA: the specific surface area.

The study also showed a significant change in the specific surface area of the Biofield Energy Treated sample that might result due to the reduction in the particle sizes after the Biofield Energy Treatment. It was observed that the specific surface area of the Biofield Energy Treated sample was significantly increased by 14.29% compared to the control L-cysteine sample. The significant correlation between the surface area and the solubility profile has been established by various scientific studies [45,46]. It was suggested that the reduced particle size of the compounds ultimately increases the effective surface area available for salvation that further enhances the solubility and dissolution of the compound and thereby the bioavailability within the body [47]. Thus, the Biofield Energy Treated L-cysteine was supposed to possess better dissolution and bioavailability profile within the body after the Biofield Energy Treatment compared with the control sample.

Powder X-ray Diffraction (PXRD) Analysis

The diffractograms corresponding to the powder XRD analysis of the control and Biofield Energy Treated samples were presented in Figure 1. Both the diffractograms showed the presence of sharp and intense peaks, which revealed the crystalline nature of the Biofield Energy Treated sample as that of the control sample. The data of both the diffractograms indicated the missing of some of the characteristic’s peaks in the Biofield Energy Treated sample along with significant alterations in the Bragg’s angle of the other peaks compared to the control sample. The diffractogram of the Biofield Energy Treated sample showed the highest peak intensity at 2θ equal to 23.05°; while it was observed at 2θ equal to 24.67° in the control sample. Besides, the peaks observed at 2θ equal to 13.24°, 33.84°, and 40.04° in the diffractogram of the control sample were not found in the Biofield Energy Treated sample. Instead, the Biofield Energy Treated sample’s diffractogram showed new peaks at 2θ equal to 23.05°, 43.42°, and 49.81°, compared to the control sample. The significant changes were also found in the peak intensities and the crystallite sizes corresponding to the characteristic peaks of the Biofield Treated sample ranging from -47.62% to 110.11% and -17.74% to -74.57%, respectively, compared to the control sample. The significant changes observed in the positioning of the characteristic diffraction peaks as well as their corresponding intensities and crystallite sizes of the Biofield Energy Treated sample compared to the control sample indicated the possible alterations in their crystalline properties after the Biofield Energy Treatment (Table 2).

The treated sample also showed a significant change in the average crystallite size (450.75 nm) that was found to be decreased significantly by 49.81% in comparison to the control sample (898 nm). The crystalline properties of the compound could be altered after the Biofield Energy Treatment as studied previously by various researchers [23,35,36,38]. The basis of such alterations was established depending on the changes observed in the peak intensities of the characteristic peaks of the Biofield Energy Treated compounds and their corresponding crystallite sizes [48,49]. In this study, the results indicated the presence of some new peaks in the treated sample’s diffractogram along with the absence of some characteristic peaks compared to the control sample that might indicate the formation of new polymorphs of L-cysteine after the Biofield Energy Treatment. There are various scientific studies which reported that the physical modifications in the crystalline structure of compounds such as, altering the crystal habits may alter the bioavailability and efficacy of the drug [50]. Thus, it is presumed that the Biofield Energy Treated sample might be more bioavailable and effective in comparison to the control L-cysteine sample.

Differential Scanning Calorimetry (DSC) Analysis

The DSC thermograms of the control and the Biofield Energy Treated samples (Figure 2) help in determining the difference in their melting temperature and latent heat [51] that may arise due to the Biofield Energy Treatment. The scientific studies previously done on L-cysteine reported the decomposition of the sample during heating instead of its sublimation as the peaks observed in the DSC thermogram coincides with the drop in the TGA thermogram. Thus, the same temperature indicated the decomposition process of L-cysteine during the thermal heating instead of melting process [51,52]. The thermograms of both the samples showed two endothermic peaks during the thermal heating process. The results indicated the minor changes in the peak temperature of both the peaks of the Biofield Energy Treated sample; however, the latent heat (Δ_{Hdecomposition}) corresponding to both peaks were significantly altered compared with the control sample. The treated sample showed a slight reduction in the peak temperature corresponding to 1st and 2nd peak by 0.20% and 0.40%; while the Δ_{Hdecomposition} was significantly altered by 11.45% and 20.79%, respectively compared to the control sample (Table 3). The DSC results revealed that the decomposition temperatures of the treated sample were similar as that of the control sample, whereas the latent heat corresponding to those temperatures was significantly increased that may occur due to some alterations in the crystal structure and molecular pattern of the L-cysteine [51,53] after the Biofield Energy Treatment. Hence, the thermal decomposition pattern of the Biofield Energy Treated was altered with respect to its latent heat compared to the control L-cysteine sample.

ΔH: Latent heat of fusion.

Thermal Gravimetric Analysis (TGA)/ Differential Thermogravimetric Analysis (DTG)

The TGA thermograms of the control and treated samples showed a significant weight loss of L-cysteine during the thermal degradation (Figure 3) and the pattern of degradation of both the samples during the heating was found similar as reported in the previous scientific studies [52]. Further data of the thermograms revealed a significant reduction in the weight loss of the treated sample compared to the control sample. The treated sample showed a 93.94% weight loss during the thermal heating that was found to be reduced by 5.59% in comparison to the total weight loss of the control sample (99.50%). Hence, the resultant residue weight of the treated sample was increased significantly by 1111.20% compared to the control L-cysteine sample (Figure 4). Moreover, the DTG analysis (Table 4) of the control and the treated sample indicated a slight alteration in the maximum thermal degradation temperature (T_max) of the Biofield Energy Treated L-cysteine in comparison with the control sample. The Tmax of the control sample was observed as 221.06ºC; while it was slightly reduced by 0.50% in the treated sample and found as 219.96 °C. Hence, the overall TGA/DTG studies indicated the increased thermal stability of the Biofield Energy Treated sample after the Biofield Energy Treatment in comparison with the control L-cysteine sample.

T_max = the temperature at which maximum weight loss takes place in TG or peak temperature in DTG.

Conclusion

This scientific study was performed to analyze the alterations in the physicochemical and thermal properties of L-cysteine that may arise due to the impact of the Trivedi Effect®-Consciousness Energy Healing Treatment in comparison to the control sample. The Biofield Energy Treated sample showed significant changes in the particle size distribution pattern that was observed to be reduced at d10, d50, d90, and D (4, 3) by 10.18%, 12.97%, 16.83%, and 14.36%, respectively, compared with the particle size values of the control L-cysteine sample. The resultant impact was also seen on the specific surface area of the Biofield Energy Treated sample after the Biofield Energy Treatment as it was significantly increased by 14.29% compared with the control L-cysteine sample. The PXRD data of both the samples revealed significant changes in the positioning of characteristics peaks of the Biofield Energy Treated sample along with the highest peak intensity compared with the peaks of the control L-cysteine’s diffractogram. The peaks having similar Bragg’s angles of the Biofield Energy Treated sample as that of the control sample also showed alterations in their peak intensities ranging from -47.62% to 110.11% and in crystallite sizes ranging from -17.74% to -74.57% in comparison to the control sample. The average crystallite size of the Biofield Energy Treated L-cysteine was also found to be significantly reduced by 49.81% compared with the control sample. The presence of two endothermic peaks in the DSC thermograms of the control and Biofield Energy Treated sample, which denoted their thermal decomposition. The Δ_{Hdecomposition} of the 1^st and 2^nd endothermic peaks were significantly increased by 11.45% and 20.79%, respectively, compared with the control L-cysteine sample.

The Biofield Energy Treated sample indicated the increased thermal stability after the Biofield Energy Treatment as the total weight loss during the thermal heating was reduced by 5.59% in comparison to the control sample, which therefore causes a remarkable increase in the residue weight by 1111.20% compared with the control L-cysteine sample. The overall analysis on the L-cysteine sample revealed the impact of the Biofield Energy Treatment on the sample that causes the decrease in particle sizes and increased specific surface area, which might help in increasing the solubility, absorption, and bioavailability of the Biofield Energy Treated sample. The impact of the Trivedi Effect® was also found on the crystalline and thermal properties of L-cysteine as the Biofield Energy Treated sample showed altered crystallinity that might form a novel polymorph with improved thermal stability of the sample, compared to the control sample. Thus, the Biofield Energy Treated L-cysteine could be useful in formulations (i.e., food, cosmetics, pharmaceuticals, etc.) which might improve the bioavailability and more efficacious in the treatment against cardiovascular disease, inflammation, angina, chronic bronchitis, chronic obstructive pulmonary disease (COPD), diabetes, osteoarthritis, flu, inflammatory bowel disease, etc.

References

1. Brosnan JT, Brosnan ME (2006) The sulfur-containing amino acids: An overview. J Nutr 136: 1636S-1640S.
2. Yin J, Ren W, Yang G, Duan J, Huang X, et al. (2016) L-Cysteine metabolism and its nutritional implications. Mol Nutr Food Res 60: 134-146.
3. Ripps H, Shen W (2012) Review: Taurine: A Very Essential amino acid. Mol Vis 18: 2673-2686.
4. Jain SK, Velusamy T, Croad JL, Rains JL, Bull R (2009) L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, oxidative stress and inhibits NFkB activation in the livers of Zucker diabetic rats. Free Radic Biol Med 46(12): 1633-1638.
5. Guijarro LG, Mate J, Gisbert JP, Perez-Calle JL, Marin-Jimenez I, et al. (2008) N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: Randomized, placebo-controlled pilot study. World J Gastroenterol 14: 2851-2857.
6. Kerksick C, Willoughby D (2005) The antioxidant role of glutathione and n-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr 2: 38-44.
7. Lobo V, Patil A, Phatak A, Chandra N (2010) Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev 4: 118-126.
8. Dekhuijzen P, van Beurden W (2006) The role for N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis 1: 99-106.
9. Mokhtari V, Afsharian P, Shahhoseini M, Kalantar SM, Moini A (2016) A review on various uses of n-acetyl cysteine. Cell journal 19: 11-17.
10. McClure EA, Gipson CD, Malcolm RJ, Kalivas PW, Gray KM (2014) Potential role of n-acetylcysteine in the management of substance use disorders. CNS Drugs 28(2): 95-106.
11. Sekhar RV, Patel SG (2011) Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr 94(3): 847-853.
12. Sadowska AM, Verbraecken J, Darquennes K, De Backer WA (2006) Role of N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis 1(4): 425-434.
13. Dean O, Giorlando F, Berk M (2011) N-acetylcysteine in psychiatry: Current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 36(2): 78-86.
14. Eakin K, Baratz-Goldstein R, Pick CG, Zindel O, Balaban CD, et al. (2014) Efficacy of N-acetyl cysteine in traumatic brain injury. PloS one 9: e90617.
15. Arranz L, Fernández C, Rodríguez A, Ribera JM, De la Fuente M (2008) The glutathione precursor N-acetylcysteine improves immune function in postmenopausal women. Free Radic Biol Med 45(9): 1252-1262.
16. Barlow RB (1974) Physicochemical properties and biological activity: Thermodynamic properties of compounds related to acetylcholine assessed from depression of freezing-point and enthalpies of dilution. Br J Pharmacol 51(3): 413-426.
17. Braakhuis HM, Park MV, Gosens I, De Jong WH, Cassee FR (2014) Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part Fibre Toxicol 11: 18.
18. Trivedi MK, Branton A, Trivedi D, Nayak G, Sethi KK, et al. (2016) Isotopic abundance ratio analysis of biofield energy treated indole using gas chromatography-mass spectrometry. Science Journal of Chemistry 4: 41-48.
19. Koster DA, Trivedi MK, Branton A, Trivedi D, Nayak G, et al. (2018) Evaluation of biofield energy treated vitamin D3 on bone health parameters in human bone osteosarcoma cells (MG-63). Biochemistry and Molecular Biology 3: 6-14.
20. Guarneri E, King RP (2015) Challenges and opportunities faced by biofield practitioners in global health and medicine: A white paper. Global Advances in Health and Medicine 4: 89-96.
21. Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 10(12): 1-23.
22. Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, et al. (2012) Use and acceptance of complementary and alternative medicine among the general population and medical personnel: A Systematic Review. Ochsner J 12(1): 45-56.
23. Trivedi MK, Mohan TRR (2016) Biofield energy signals, energy transmission and neutrinos. American Journal of Modern Physics 5: 172-176.
24. Nayak G, Altekar N (2015) Effect of biofield treatment on plant growth and adaptation. J Environ Health Sci 1: 1-9.
25. Branton A, Jana S (2017) The influence of energy of consciousness healing treatment on low bioavailable resveratrol in male Sprague Dawley rats. International Journal of Clinical and Developmental Anatomy 3: 9-15.
26. Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, et al. (2015) Morphological characterization, quality, yield and DNA fingerprinting of biofield energy treated alphonso mango (Mangiferaindica L.). Journal of Food and Nutrition Sciences 3: 245-250.
27. Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, et al. (2015) Evaluation of biochemical marker – Glutathione and DNA fingerprinting of biofield energy treated Oryza sativa. American Journal of Bio Science 3: 243-248.
28. Kinney JP, Trivedi MK, Branton A, Trivedi D, Nayak G, et al. (2017) Overall skin health potential of the biofield energy healing based herbomineral formulation using various skin parameters. American Journal of Life Sciences 5: 65-74.
29. Branton A, Jana S (2017) Effect of the biofield energy healing treatment on the pharmacokinetics of 25-hydroxyvitamin D3 [25(OH)D3] in rats after a single oral dose of vitamin D3. American Journal of Pharmacology and Phytotherapy 2(1): 11-18.
30. Singh J, Trivedi MK, Branton A, Trivedi D, Nayak G, et al. (2017) Consciousness energy healing treatment based herbomineral formulation: A safe and effective approach for skin health. American Journal of Pharmacology and Phytotherapy 2: 1-10.
31. Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) Evaluation of biofield modality on viral load of Hepatitis B and C viruses. J Antivir Antiretrovir 7: 083-088.
32. Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) An impact of biofield treatment: Antimycobacterial susceptibility potential using BACTEC 460/MGIT-TB System. Mycobact Dis 5: 189.
33. Trivedi MK, Branton A, Trivedi D, Nayak G, Charan S, et al. (2015) Phenotyping and 16S rDNA analysis after biofield treatment on Citrobacter braakii: A urinary pathogen. J Clin Med Genom 3: 129.
34. Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, et al. (2015) Effect of biofield treated energized water on the growth and health status in chicken (Gallus gallus domesticus). Poult Fish Wildl Sci 3: 140.
35. Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, et al. (2015) Analysis of physical, thermal, and structural properties of biofield energy treated molybdenum dioxide. International Journal of Materials Science and Applications 4: 354-359.
36. Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, et al. (2015) The potential impact of biofield energy treatment on the physical and thermal properties of silver oxide powder. International Journal of Biomedical Science and Engineering 3: 62-68.
37. Trivedi MK, Branton A, Trivedi D, Shettigar H, Bairwa K, et al. (2015) Fourier transform infrared and ultraviolet-visible spectroscopic characterization of biofield treated salicylic acid and sparfloxacin. Nat Prod Chem Res 3: 186.
38. Trivedi MK, Branton A, Trivedi D, Nayak G, Nykvist CD, et al. (2017) Evaluation of the Trivedi Effect®- Energy of Consciousness Energy Healing Treatment on the physical, spectral, and thermal properties of zinc chloride. American Journal of Life Sciences 5: 11-20.
39. Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) Spectroscopic characterization of biofield treated metronidazole and tinidazole. Med chem 5: 340-344.
40. Trivedi MK, Sethi KK, Panda P, Jana S (2017) Physicochemical, thermal and spectroscopic characterization of sodium selenate using XRD, PSD, DSC, TGA/DTG, UV-vis, and FT-IR. Marmara Pharmaceutical Journal 21/2: 311-318.
41. Trivedi MK, Sethi KK, Panda P, Jana S (2017) A comprehensive physicochemical, thermal, and spectroscopic characterization of zinc (II) chloride using X‑ray diffraction, particle size distribution, differential scanning calorimetry, thermogravimetric analysis/differential thermogravimetric analysis, ultraviolet‑visible, and Fourier transform‑infrared spectroscopy. International Journal of Pharmaceutical Investigation 7: 33-40.
42. Zhang T, Paluch K, Scalabrino G, Frankish N, Healy AM, et al. (2015) Molecular structure studies of (1S,2S)-2-benzyl-2,3-dihydro-2-(1Hinden-2-yl)-1H-inden-1-ol. J Mol Struct 1083: 286-299.
43. (1997) Desktop X-ray Diffractometer Mini Flex+. The Rigaku Journal 14: 29-36.
44. Langford JI, Wilson AJC (1978) Scherrer after sixty years: A survey and some new results in the determination of crystallite size. J Appl Cryst 11: 102-113.
45. Loh ZH, Samanta AK, Heng PWS (2015) Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J Pharm 10(4): 255-274.
46. Khadkaa P, Roa J, Kim H, Kim I, Kim JT, et al. (2014) Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm 9(4): 304-316.
47. Hu J, Johnston KP, Williams RO (2004) Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm 30(3): 233-245.
48. Trivedi MK, Branton A, Trivedi D, Nayak G, Lee AC, et al. (2017) Evaluation of the impact of biofield energy healing treatment (the Trivedi Effect®) on the physicochemical, thermal, structural, and behavioral properties of magnesium gluconate. International Journal of Nutrition and Food Sciences 6: 71-82.
49. Trivedi MK, Branton A, Trivedi D, Nayak G, Plikerd WD, et al. (2017) Evaluation of the physicochemical, spectral, thermal and behavioral properties of sodium selenate: Influence of the energy of consciousness healing treatment. American Journal of Quantum Chemistry and Molecular Spectroscopy 2: 18-27.
50. Savjani KT, Gajjar AK, Savjani JK (2012) Drug Solubility: Importance and Enhancement Techniques. ISRN Pharmaceutics 2012: Article ID 195727.
51. Zhao Z, Xie M, Li Y, Chen A, Li G, et al. (2015) Formation of curcumin nanoparticles via solution enhanced dispersion by supercritical CO₂. Int J Nanomedicine 10: 3171-3181.
52. Weiss IM, Muth C, Drumm R, Kirchner HOK (2018) Thermal decomposition of the amino acids glycine, cysteine, aspartic acid, asparagine, glutamic acid, glutamine, arginine and histidine. BMC Biophysics 11: 2.
53. Sovizi MR, Hajimirsadeghi SS, Naderizadeh B (2009) Effect of particle size on thermal decomposition of nitrocellulose. J Hazard Mater 168(2-3): 1134-1139.